Literature DB >> 686971

Test dose response in schizophrenia: chlorpromazine blood and saliva levels.

P R May, T Van Putten, D J Jenden, A K Cho.   

Abstract

A gas chromatographic/mass spectrometric method for measuring chlorpromazine using 2H6--labeled chlorpromazine as an internal standard has the potential for considerable precision and specificity. Results are reported of chlorpromazine levels in plasma and saliva after administration of a single test dose to 13 schizophrenic patients in a tightly designed experiment. There was a clear and substantive relationship between blood and saliva levels of chlorpromazine, both following a typical decay curve. Saliva and plasma levels were strongly associated for a particular patient, and there was even a strong consistency in saliva-plasma ratios between patients, with an overall statistically significant correlation between plasma and saliva levels for all measurement on all 13 patients. In general, it seems that saliva sampling has great potential as a simple noninvasive technique for investigation of chlorpromazine and other antipsychotic drugs in psychotic patients. Nevertheless, for the moment, it should be regarded as strictly experimental and not suitable for immediate clinical application.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686971     DOI: 10.1001/archpsyc.1978.01770330065005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  4 in total

1.  Single-dose kinetics of the neuroleptic drug perazine in psychotic patients.

Authors:  U Breyer-Pfaff; K Nill; H W Schied; H J Gaertner; H Giedke
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure.

Authors:  T B Cooper; N Bark; G M Simpson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 3.  A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics Research.

Authors:  David J Beale; Oliver A H Jones; Avinash V Karpe; Saravanan Dayalan; Ding Yuan Oh; Konstantinos A Kouremenos; Warish Ahmed; Enzo A Palombo
Journal:  Int J Mol Sci       Date:  2016-12-23       Impact factor: 5.923

4.  Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

Authors:  M Plaze; D Attali; A-C Petit; M Blatzer; E Simon-Loriere; F Vinckier; A Cachia; F Chrétien; R Gaillard
Journal:  Encephale       Date:  2020-05-16       Impact factor: 1.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.